Retatrutide Side Effects The Phase 2 retatrutide trial (Jastreboff et al., NEJM 2023) reported gastrointestinal adverse events as the dominant side-effect pattern, consistent with other GLP-1-class drugs
Chi YQ, Yao Y, Zhang WH, Zhang ZH, Wang YH, Hao W (2025) Docosahexaenoic acid supplementation for neonatal hyperbilirubinemia: a double-blind, randomized clinical trial
npj Aging and Mechanisms of Disease, 3 (1), 9
This presents an ideal scenario to test the viability of medication repurposing, the team said
This customized procedure gently exfoliates and hydrates the skin, helping to improve texture, reduce roughness, and reveal a more radiant and youthful appearance